GGrantIndex
Sort

53,477 grants matching addiction

Molecular genetics of sensory modulation of motor programs

$569,791
Niels Ringstad · New York University School Of Medicine · R35 · FY2020 · GM

Molecular genetics of sensory modulation of motor programs

$569,791
Niels Ringstad · New York University School Of Medicine · R35 · FY2019 · GM

Spatiotemporal signaling and trafficking of the mu-opioid receptor

$569,713
Ruth Huttenhain · Stanford University · R01 · FY2025 · DA

Cannabinoid Receptors and Associated Proteins-Renewal

$569,659
Allyn C Howlett · Wake Forest University Health Sciences · R01 · FY2025 · DA

Cell model for KSHV infection and genetic manipulation

$569,633
Shou-Jiang Gao · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA

Reelin Signaling and Function in Cocaine Response

$569,580
Jeremy J Day · University Of Alabama At Birmingham · R01 · FY2021 · DA

Reelin Signaling and Function in Cocaine Response

$569,580
Jeremy J Day · University Of Alabama At Birmingham · R01 · FY2023 · DA

Reelin Signaling and Function in Cocaine Response

$569,580
Jeremy J Day · University Of Alabama At Birmingham · R01 · FY2022 · DA

Reelin Signaling and Function in Cocaine Response

$569,580
Jeremy J Day · University Of Alabama At Birmingham · R01 · FY2024 · DA

Reelin Signaling and Function in Cocaine Response

$569,580
Jeremy J Day · University Of Alabama At Birmingham · R01 · FY2025 · DA

Profiling DataBase for Cocaine Medications

$569,570
Novascreen Biosciences Corporation · R44 · FY2002 · DA

NLRP inflammasome directed activation of the innate immune system produces synaptic damage in EcoHIV infected mice self-administering fentanyl

$569,557
Norman J Haughey · Johns Hopkins University · R01 · FY2023 · DA

Core 2: Research Training and Education p330-341

$569,553
Suchitra Krishnan-Sarin · Yale University · P50 · FY2013 · DA

Core B: Tobacco Product Evaluation and Exposure Core

$569,521
Daniel Joseph Conklin · American Heart Association · P50 · FY2015 · HL

Lasting Neurological Effects of Perinatal Opioids

$569,515
Mary Kay Lobo · University Of Maryland Baltimore · R01 · FY2025 · DA

Integrating Multiple Omics to Illuminate Gene Networks Underlying Cigarette Smoking and Opioids.

$569,455
Dana B Hancock · Research Triangle Institute · R01 · FY2023 · DA

Objective tests utilizing Vibrational Spectroscopy for Diagnosis and Severity of Fibromyalgia and Related Pain Syndromes

$569,451
Kevin Victor Hackshaw · University Of Texas At Austin · R33 · FY2025 · NS

Project 3: Flavors and E-cigarette Effects in Adolescent Smokers p238-273

$569,427
Suchitra Krishnan-Sarin · Yale University · P50 · FY2016 · DA

Varenicline OTC Trial on Efficacy and Safety

$569,415
Scott J Leischow · Arizona State University-Tempe Campus · R01 · FY2018 · DA

HIV ASSOCIATED NEPHROPATHY IN DRUG ADDICTS

$569,396
Feinstein Institute For Medical Research · R01 · FY2005 · DA

Preclinical studies of a heroin/morphine vaccine for opiate addiction

$569,342
Paul Pentel · Hennepin Healthcare Research Institute · R01 · FY2014 · DA

An Evaluation of Sober Living Houses

$569,334
Douglas L Polcin · Public Health Institute · R01 · FY2006 · AA

SAFETY OF A NICOTINE REDUCTION STRATEGY

$569,308
University Of California San Francisco · R01 · FY2001 · CA

Stress and Drug Use Vulnerability in the African American Community

$569,305
Ezemenari M Obasi · University Of Houston · R01 · FY2014 · DA

Training Motivational Interviewing Using Live Supervision

$569,292
Edward V Nunes · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2010 · DA